A Phase 4, Open-Label Study of the Pharmacokinetics and Safety of Diclofenac Potassium Oral Solution in Pediatric Subjects (Ages 2-12 Years) With Mild to Moderate Acute Pain
Phase of Trial: Phase IV
Latest Information Update: 14 Jul 2017
At a glance
- Drugs Diclofenac potassium (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors DepoMed
- 10 Mar 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Dec 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Jun 2016 according to ClinicalTrials.gov record.
- 06 May 2015 Planned primary completion date changed from 1 May 2015 to 1 Dec 2015, according to ClinicalTrials.gov record.